| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99284 |
Emergency department visit for the evaluation and management, high severity |
2,629 |
2,275 |
$856K |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
2,646 |
2,345 |
$631K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
895 |
783 |
$215K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
818 |
701 |
$86K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
181 |
148 |
$63K |
| 71045 |
Radiologic examination, chest; single view |
1,047 |
840 |
$48K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
362 |
273 |
$44K |
| 70450 |
Computed tomography, head or brain; without contrast material |
353 |
317 |
$40K |
| 80053 |
Comprehensive metabolic panel |
2,791 |
2,138 |
$37K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
785 |
693 |
$35K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
132 |
121 |
$28K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
712 |
532 |
$22K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
944 |
807 |
$22K |
| 59025 |
Fetal non-stress test |
125 |
78 |
$22K |
| 81001 |
|
1,703 |
1,287 |
$21K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
277 |
210 |
$20K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
3,404 |
2,540 |
$19K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
560 |
415 |
$18K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
171 |
153 |
$15K |
| 87631 |
|
750 |
660 |
$15K |
| 36415 |
Collection of venous blood by venipuncture |
4,025 |
2,912 |
$11K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
366 |
99 |
$10K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
245 |
195 |
$9K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
236 |
177 |
$9K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
60 |
57 |
$8K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
1,367 |
1,076 |
$8K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
133 |
89 |
$8K |
| 20610 |
|
427 |
204 |
$7K |
| 71046 |
Radiologic examination, chest; 2 views |
143 |
128 |
$6K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
160 |
147 |
$6K |
| G0378 |
Hospital observation service, per hour |
92 |
38 |
$5K |
| 66984 |
Extracapsular cataract removal with insertion of intraocular lens prosthesis |
12 |
12 |
$5K |
| 80306 |
|
304 |
220 |
$4K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
712 |
519 |
$4K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
575 |
306 |
$3K |
| 86850 |
|
490 |
377 |
$3K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
42 |
32 |
$3K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
683 |
345 |
$3K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
94 |
69 |
$3K |
| J1097 |
Phenylephrine 10.16 mg/ml and ketorolac 2.88 mg/ml ophthalmic irrigation solution, 1 ml |
14 |
14 |
$2K |
| V2632 |
Posterior chamber intraocular lens |
14 |
14 |
$2K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
32 |
25 |
$2K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
230 |
199 |
$2K |
| 86592 |
|
289 |
210 |
$2K |
| 86901 |
|
226 |
176 |
$2K |
| 86900 |
|
226 |
176 |
$2K |
| 80061 |
Lipid panel |
354 |
335 |
$2K |
| 81000 |
|
647 |
539 |
$2K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
94 |
69 |
$2K |
| 93041 |
|
86 |
73 |
$2K |
| 84484 |
|
686 |
566 |
$2K |
| 82947 |
|
358 |
245 |
$2K |
| 84443 |
Thyroid stimulating hormone (TSH) |
747 |
663 |
$2K |
| 87653 |
|
50 |
38 |
$1K |
| 83880 |
|
374 |
289 |
$1K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
156 |
125 |
$1K |
| 81025 |
|
156 |
143 |
$1K |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
321 |
211 |
$1K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
218 |
207 |
$1K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
128 |
86 |
$1K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
254 |
240 |
$1K |
| 83735 |
|
594 |
450 |
$1K |
| 83690 |
|
313 |
271 |
$1K |
| 85730 |
|
274 |
249 |
$938.15 |
| 85027 |
|
487 |
377 |
$926.22 |
| 85610 |
|
316 |
287 |
$831.14 |
| 83605 |
|
287 |
243 |
$688.55 |
| 99307 |
|
62 |
49 |
$676.77 |
| 94760 |
|
34 |
12 |
$520.69 |
| 87186 |
|
112 |
101 |
$510.21 |
| 80050 |
General health panel |
13 |
12 |
$506.43 |
| 96376 |
|
86 |
56 |
$505.59 |
| 85007 |
|
409 |
314 |
$417.80 |
| 84439 |
|
105 |
81 |
$402.58 |
| 87205 |
|
41 |
31 |
$299.93 |
| 87040 |
|
105 |
85 |
$298.25 |
| 82950 |
|
64 |
48 |
$260.69 |
| 86803 |
|
35 |
27 |
$209.73 |
| 83540 |
|
46 |
42 |
$174.39 |
| J2704 |
Injection, propofol, 10 mg |
52 |
43 |
$164.54 |
| 84466 |
|
31 |
29 |
$156.49 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
284 |
199 |
$145.47 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
294 |
256 |
$131.40 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
52 |
41 |
$119.67 |
| 87340 |
|
18 |
15 |
$109.41 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
427 |
350 |
$84.28 |
| 86762 |
|
17 |
14 |
$83.63 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
290 |
257 |
$77.32 |
| 87088 |
|
14 |
13 |
$68.94 |
| 87077 |
|
14 |
14 |
$58.42 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
211 |
193 |
$56.12 |
| G0475 |
Hiv antigen/antibody, combination assay, screening |
12 |
12 |
$54.06 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
78 |
68 |
$44.13 |
| 82248 |
|
13 |
13 |
$43.28 |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
33 |
26 |
$42.01 |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
28 |
15 |
$30.73 |
| 82962 |
|
23 |
12 |
$21.50 |
| 85018 |
|
24 |
12 |
$20.83 |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
12 |
12 |
$4.50 |
| J2272 |
Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg |
15 |
12 |
$3.11 |